Betaine concentration as a determinant of fasting total homocysteine concentrations and the effect of folic acid supplementation on betaine concentrations

American Journal of Clinical Nutrition

Volumn 81, Issue 6, 2005, Pages 1378-1382

  Melse Boonstra, Alida ^a   Holm, Pål I ^b   Ueland, Per M ^b   Olthof, Margreet ^a   Clarke, Robert ^c   Verhoef, Petra ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF BERGEN   (Norway)

^c RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Betaine; Folate; Folic acid supplementation; Healthy population; Humans; tHcy; Total homocysteine

Indexed keywords

BETAINE; CHOLINE; DIMETHYLGLYCINE; FOLIC ACID; HOMOCYSTEINE; ANTIANEMIC AGENT; METHIONINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; DOSE RESPONSE; METABOLISM; METHYLATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; AGED; BETAINE; CHOLINE; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FASTING; FEMALE; FOLIC ACID; HEMATINICS; HOMOCYSTEINE; HUMANS; MALE; METHIONINE; METHYLATION; MIDDLE AGED;

EID: 21944456427     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/81.6.1378     Document Type: Article

References (23)

1. The Homocysteine Studies collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002;288:2015-22.
2. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: a meta-analysis of randomised trials. BMJ 1998;316:894-8.
3. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Haemost 2000;26:341-8.
4. Ubbink JB, Vermaak WJ, van der Merwe A, et al. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124: 1927-33.
5. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr 2003;133: 1302-7.
6. Garrow TA. Betaine-dependent remethylation. In: Carmel R, Jacobsen DW, eds. Homocysteine in health and disease. Cambridge, United Kingdom: Cambridge University Press, 2001:145-52.
7. Smolin LA, Benevenga NJ, Berlow S. The use of betaine for the treatment of homocystinuria. J Pediatr 1981;99:467-72.
8. Wilcken DE, Wilcken B, Dudman NP, Tyrrell PA. Homocystinuria-the effects of betaine in the treatment of patients not responsive to pyridoxine. J Intern Med 1983;309:448-53.
9. Steenge GR, Verhoef P, Katan MB. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr 2003;133: 1291-5.
10. Olthof MR, van Vliet T, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr 2003;133:4135-8.
11. Holm P, Bleie Ø, Ueland PM et al. Betaine as determinant of postmethionine load total plasma homocysteine before and after vitamin B supplementation. Arterioscler Thromb Vasc Biol 2004;24:1-7.
12. Selhub J, Seyoum E, Pomfret EA, Zeisel SH. Effects of choline deficiency and methotrexate treatment upon liver folate content and distribution. Cancer Res 1991;51:16-21.
13. Varela-Moreiras G, Selhub J, daCosta KA, Zeisel SH. Effect of chronic choline deficiency in rats on liver folate content and distribution. J Nutr Biochem 1992;3:519-21.
14. Kim Y-I, Miller JW, daCosta KA et al. Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. J Nutr 1994;124:2197-203.
15. Van Oort FVA, Melse-Boonstra A, Brouwer IA, et al. Folic acid and plsma homocysteine reduction in older adults: a dose finding study. Am J Clin Nutr 2003;77:1318-23.
16. Holm P, Ueland PM, Kvalheim G, Lien EA. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 2003;49:286-94.
17. Ubbink JB, Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-6.
18. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-79.
19. Schwab U, Törrönen A, Toppinen L, et al. Betaine supplementation decreases plasma homocystene concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr 2002;76:961-7.
20. Schwahn BC, Chen Z, Laryea MD, et al. Homocysteine-betaine interactions in a mutine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J 2003;17:512-4.
21. Allen RH, Stabler SP, Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 1993;42:1448-60.
22. Nelen WL. Hyperhomocysteinameia and human reproduction. Clin Chem Lab Med 2001;39:758-63.
23. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.